Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior reviewers, according to Auchincloss.
FDA’s Commissioner’s Priority Voucher Program ‘Shrouded in Secrecy,’ Democratic Rep Says Read More »
Instead of joining the increasingly crowded GLP-1 arena, GSK will focus its efforts downstream of obesity—a push currently anchored by its Phase III-ready FGF21 analog efimosfermin alfa for liver fibrosis.
GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity Read More »
After review, Amgen is certain that Tavneos is effective and has a favorable benefit-risk profile. The company informed the FDA on January 28 that they would not pull the drug.
Amgen Will Not Heed FDA Request To Withdraw Rare Disease Drug Tavneos Read More »
Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its investigational obesity drug MariTide will continue to provide competitive weight loss even at monthly or longer schedules.
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods Read More »
Unos científicos han venido realizando experimentos con la bacteria Sporosarcina pasteurii, que vive en suelos, con el propósito de determinar hasta qué punto resultaría práctico usarla en Marte para aprovechar una peculiar capacidad que este microorganismo posee y …
Un nuevo modelo informático del cerebro, basado en gran medida en su biología y fisiología, no solo ha aprendido una tarea simple de aprendizaje de categorías visuales con la misma eficacia que los animales de laboratorio, sino que incluso ha permitido descubrir una clase …
Una réplica informática del cerebro de un animal logra comportarse igual que este Read More »
Unos nuevos microrrobots, capaces de desplazarse por el interior del cuerpo humano, prometen ser capaces de destruir tumores cancerosos con gran eficacia. Cuanto más pequeño es un robot, mayor es su capacidad de adentrarse por espacios pequeños, incluyendo espacios del …
Novartis will still be on the lookout for early-stage deals under $2 billion, and later-stage agreements around a product that could reach the market within five years, CEO Vas Narasimhan said Wednesday.
Durante eventos especiales como los Gaming Days, las compras de hardware y accesorios relacionados con los videojuegos se disparan. Aprovechando las mejores ofertas en gaming en portátiles, tarjetas gráficas, monitores y periféricos, muchos usuarios renuevan sus equipos o comple …
Ranking de los productos gaming más vendidos durante los Gaming Days Read More »
Pfizer announces the first data from its Metsera-acquired pipeline just ahead of its earnings call, where analysts pressed execs for more details; Merck and Roche also released Q4 and full year earnings, with Eli Lilly, Novo Nordisk and others reporting Wednesday; REGENXBIO hits a regulatory snag ahead of its upcoming PDUFA; more.
Pfizer’s Metsera Data, 2025 Earnings, the FDA and REGENXBIO, Psychedelics and IPOs Read More »
